FDA halts trial after first CAR T-associated patient death
September 6, 2017Research and Development CAR T, CAR-T, Cancer, FDA, cellectis, leukaemia, patient death, pharma, pharmaceutical
French clinical-stage biopharma firm Cellectis has received an order from the FDA to halt its study of CAR T therapy …
Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million
September 6, 2017Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical
Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …
Anti-HIV drug PrEP proves safety in gay and bisexual adolescents
September 6, 2017Research and Development Gilead, HIV, Pharamceuticals, PrEP, Truvada, health, medicine, pharma
A new study has found that pre-exposure prophylaxis (PrEP) drugs such as Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate), which pre-emptively protects …
Real-world data prove efficacy of Eisai and Bial’s epilepsy treatment
September 6, 2017Research and Development Bial, Eisai, Zebinix, epilepsy, pharma
Bial and Eisai have released real-world data which support the efficacy of Zebinix (eslicarbazepine acetate) in the treatment of partial-onset …
Novartis exec designated as new CEO after Jimenez announces retirement
September 5, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, a, joe jimenez, phar, pharma, pharmaceuticals
Novartis has announced that its Chief Executive, Joe Jimenez, is set to retire next year. In his place, Vasant Narasimhan …
Takeda’s Ninlaro knocked back by NICE for second time
September 5, 2017Research and Development, Sales and Marketing Ninlaro, Takeda, biotech, drugs, pharma, pharmaceutical
NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …
Merck KGaA commits to continued partnership with Ugandan Government
September 5, 2017Manufacturing and Production, Medical Communications Merck, infertility, life sciences, pharma, pharmaceuticals, uganda
Merck KGaA has revealed plans to continue its commitment to a key partnership with the Ugandan Government via its non-profit …
Pfizer’s drug back on the market after proving safety
September 5, 2017Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical
Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …
Novartis celebrates success of Gilenya in paediatric multiple sclerosis
September 5, 2017Manufacturing and Production, Research and Development MS, Novartis, gilenya, health, multiple sclerosis, pharma, pharmaceuticals
Novartis has announced results of its Phase 3 study investigating the safety and efficacy of Gilenya (fingolimod) , finding that …
Merck KGaA to streamline business with $1bn healthcare sale
September 5, 2017Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical
Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
Asthma drugs reduce Parkinson’s risk by 50%, decade-long study finds
September 5, 2017Manufacturing and Production, Research and Development Parkinson's, Parkinson's disease, asthma, pharma, pharmaceuticals, salbutamol
A study from the Department of Global Public Health and Primary Care at the University of Bergen (UiB) in Norway …
12% of the UK have hearts ten years older than they are, Public Health England finds
September 4, 2017Research and Development, Sales and Marketing British Heart Foundation, Public Health England, cardiovascular disease, heart attack, heart health, stroke
New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …
Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle
September 4, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical
The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …
NHS needs emergency £350 million to survive winter
September 4, 2017Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical
NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …
Takeda partners up to develop “next generation” CAR T solid tumour therapy
September 4, 2017Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals
Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …
Sanofi backs out of controversial Zika vaccine project
September 4, 2017Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical
Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
Novartis CEO Jimenez announces retirement in 2018
September 4, 2017Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals
Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …
Top Ten most popular articles on Pharmafile.com this week
September 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten
This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …
R&D tax credits: A novel approach to supply chain funding
September 1, 2017Manufacturing and Production, Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical, tax credits
Jenny Tragner, director at R&D tax credit consultancy ForrestBrown and member of HMRC’s R&D Consultative Committee, says R&D tax credits …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
